Anticoagulation in COVID-19: a single-center retrospective study
Sohaib Roomi, Maryum Saddique, Waqas Ullah, Shujaul Haq, Ammar Ashfaq, John Madara, Margot Boigon
Abstract
In patients with COVID-19, therapeutic anticoagulation offers a significant reduction in the rate of in-hospital mortality, upgrade to intensive medical care, and invasive mechanical ventilation. It should be preferred over prophylactic anticoagulation in COVID-19 patients unless randomized controlled trials prove otherwise.
Topics & Concepts
MedicineRetrospective cohort studyOdds ratioConfidence intervalIntensive care unitMechanical ventilationInternal medicineLogistic regressionDialysisMortality rateIntensive careAcute kidney injuryCohortIntensive care medicineCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and Treatment